|
Journal of Environmental BiologypISSN: 0254-8704 ; eISSN: 2394-0379 ; CODEN: JEBIDP |
|
Google Search the Journal web-site: |
Abstract - Issue Jul 2008, 29 (4) BackProduction of polyclonal
antibody against recombinant ORF 112 L of rock bream (Oplegnathus fasciatus)
iridovirus (RBIV) and in vitro neutralization Yun Im
Kim1, Yu Mi Ha1, Yoon Kwon Nam2, Ki Hong Kim3 and Sung Koo
Kim*1 1Department of Biotechnology
and Bioengineering, (Received: February 12,
2007; Revised received: March 01, 2008; Accepted: March 08, 2008) Abstract: Rock
bream iridovirus (RBIV) is a causative agent of
epizootics among cultured rock bream (Oplegnathus fasciatus) in Korea. In this study, the immunogenic
property of ankyrin repeats gene (ORF 112L) from RBIV
was evaluated to develop vaccines against RBIV. ORF 112L of RBIV was cloned
into expression vector of pGEX-4T-1. The recombinant protein was successfully
expressed using E. coli BL21 (DE3). The soluble recombinant RBIV protein was
applied to affinity column for the purification of the protein. Mice were
immunized by the injection of purified recombinant protein to produce
polyclonal antibodies. ELISA was carried out to identify the immune reaction
abilities of polyclonal antibody to recombinant protein. The antigenic property
of this protein was evaluated by using in vitro neutralization with BF-2 cells.
In neutralization test, BF-2 cells infected with the mixture of RBIV and antisera containing anti-GST-ORF 112L polyclonal antibody
were healthy showing few cytopathic effect (CPE)
similar with the negative control (without RBIV). These studies suggest that
the protein from the ankyrin repeats gene, ORF 112L
of RBIV may play an important role in the mechanism of infection. Also, it can
be possible to develop protein or gene vaccines using ORF 112L against RBIV. Key
words: Iridovirus,
Ankyrin repeats protein, Polyclonal antibody, Protein vaccine,
Neutralization PDF
of full length paper is available with author (skkim@pknu.ac.kr) Copyright © 2008 Triveni Enterprises. All rights reserved. No part of the Journal can be
reproduced in any form without prior permission. Responsibility regarding
the authenticity of the data, and the acceptability of the conclusions enforced
or derived, rest completely with the author(s). |